Use of B Vitamins in Pharmacotherapy of Tuberculosis: Retrospective and Marketing Analysis

Authors

DOI:

https://doi.org/10.53933/sspmpm.v4i3.154

Keywords:

tuberculosis, vitamins, antioxidants, B vitamins, thiamin, riboflavin, pantothenic acid, pyridoxine, cyanocobalamin

Abstract

The article provides a comprehensive summary of research findings on the application of group B vitamins in the pharmacotherapy of tuberculosis. This study is grounded in both retrospective and marketing analyses, spanning from 1950 to 2024 and utilizing prominent scientific databases. The findings indicate a significant potential benefit of antioxidant vitamins in the prevention and treatment of tuberculosis, attributed to their antioxidant properties and beneficial effects on the immune system. The marketing analysis highlights the broad availability and popularity of group B vitamins in the Ukrainian market, enhancing the accessibility and economic feasibility of these products. The research offers crucial insights for medical practice and lays a foundation for future studies aimed at advancing tuberculosis prevention and treatment, particularly under conditions of heightened infection risk. Additionally, the article underscores the importance of integrating these vitamins into therapeutic protocols, which could lead to more effective management strategies for tuberculosis and possibly other infectious diseases. By identifying gaps in current treatment approaches and highlighting the economic advantages of group B vitamins, the study also paves the way for public health initiatives to incorporate these findings into broader health policies. This comprehensive approach ensures that both the medical community and policymakers are informed, facilitating a coordinated effort in combating tuberculosis on multiple fronts.

Author Biography

Alina Osyntseva, Lviv Medical University

References

Tuberculosis treatment: coverage and outcomes. WHO. 2022. URL: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023/tb-diagnosis---treatment/tb-treatment-and-treatment-coverage

Shapovalov (Jr.) V., Shapovalova V., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. Nо.1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.

Vovk D., Puhach O., Bachynska L. et al. The Role of the general practitioner-family doctor in the pharmacotherapy of Tuberculosis during the war. SSP Modern Pharmacy and Medicine. 2023. Vo.3. No.3. P.1-7. URL: https://doi.org/10.53933/sspmpm.v3i3.102 DOI: https://doi.org/10.53933/sspmpm.v3i3.102

Patti G., Pellegrino C., Ricciardi A. et al. Potential Role of Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review. Antibiotics (Basel). 2021. Vol. 10. Iss. 11. P. 1354. Doi: 10.3390/antibiotics10111354. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614960/ DOI: https://doi.org/10.3390/antibiotics10111354

Shapovalova V.O., Mykhailov V.S., Shapovalov V.V. The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice. Fiziolohichnyi zhurnal. 1999. Vol.45. Iss.3. P.114–117. URL: https://pubmed.ncbi.nlm.nih.gov/10439301/

Shapovalova V.A., Shapovalov V.V. The clinical efficacy of the combined drug agent Valcophen in children. Likars'ka sprava. 1999. No.1. P. 124–126. URL: https://pubmed.ncbi.nlm.nih.gov/10424023/

Shapovalova V.O., Shapovalov V.V. Spasmophilia in children and the anticonvulsant properties of a new Ukrainian preparation containing a pyrimidine derivative. Fiziol. Zh. 1998. Vol.44. No.5-6. Р.102-105. URL: https://pubmed.ncbi.nlm.nih.gov/9866032/. DOI: https://doi.org/10.1049/ir:19980309

Shapovalova V.O., Chernykh V.P. The physiological properties of the action of a new analgesic and antipyretic preparation. Fiziol. Zh. 1997. Vol. 43. No.1-2. P. 117-121. URL: https://pubmed.ncbi.nlm.nih.gov/9221112/.

Shapovalova V.O. Paracetamol pharmacokinetics in the blood plasma of sexually immature rabbits with the use of the new Paravit preparation. Fiziol. Zh. 1995. Vol. 41. No.5-6. P. 57-60. URL: https://pubmed.ncbi.nlm.nih.gov/9026394/.

Shapovalova V.O. The effect of Val'kofen tablets for children on the function of the gastrointestinal tract and liver in an experiment. Fiziol. Zh. 1995. Vol.41. No.5-6. Р.111-116. URL: https://europepmc.org/article/med/9026383.

Martineau A., Timms P., Bothamley G. et al. High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011. Vol. 377. Iss. 9761. P. 242–250. Doi: 10.1016/S0140-6736(10)61889-2. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176755/ DOI: https://doi.org/10.1016/S0140-6736(10)61889-2

Shapovalova V. Post-Traumatic Stress Disorder: administration, clinical and pharmacological, organizational and legal, pharmaceutical management, recent case studies. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.1. P.1-8. URL: https://doi.org/10.53933/sspmpm.v4i1.123 DOI: https://doi.org/10.53933/sspmpm.v4i1.123

Shapovalova V. Pharmacotherapy of Depressive disorders in conditions of coronavirus disease: pharmacoeconomic experimental study. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.3. P.1-11. URL: https://doi.org/10.53933/sspmpm.v3i3.101 DOI: https://doi.org/10.53933/sspmpm.v3i3.101

Shapovalova V. Extemporaneous preparations in the pharmacotherapy of nervous system disorders: pharmaceutical management, marketing, analysis, application. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.4. P.1-7. URL: https://doi.org/10.53933/sspmpm.v3i4.111 DOI: https://doi.org/10.53933/sspmpm.v3i4.111

Hayduchok I., Tukhar I., Shapovalov V. Chronic Pancreatitis, comorbid with alcohol addiction: epidemiology, causes, developmental features, symptoms and supportive pharmaceutical therapy. SSP Modern Pharmacy and Medicine. 2022. Vol.2. No.2. P.1-13. URL: https://doi.org/10.53933/sspmpm.v2i2.46 DOI: https://doi.org/10.53933/sspmpm.v2i2.46

Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.1. Р.1–13. URL: https://doi.org/10.53933/sspmpm.v2i1.37 DOI: https://doi.org/10.53933/sspmpm.v2i1.37

Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P. 1–24. URL: https://doi.org/10.53933/sspmpm.v2i4.69. DOI: https://doi.org/10.53933/sspmpm.v2i4.69

Osyntseva A. Tuberculosis: pharmacognosy, medicinal plant raw materials, medicinal plants, phytotherapy. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.1. P.1-10. P.1-10. URL: https://doi.org/10.53933/sspmpm.v4i1.130 DOI: https://doi.org/10.53933/sspmpm.v4i1.130

Osyntseva A. Administration of drugs for pharmacotherapy of Tuberculosis according to GSP requirements. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.2. P.1-17. URL: https://doi.org/10.53933/sspmpm.v4i2.140 DOI: https://doi.org/10.53933/sspmpm.v4i2.140

Osyntseva A., Shapovalov V. Management and marketing of circulation of first-line antituberculosis medicines: use of innovative research technologies. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.4. P.1-13. URL: https://doi.org/10.53933/sspmpm.v3i4.114 DOI: https://doi.org/10.53933/sspmpm.v3i4.114

Osyntseva A. Forensic and pharmaceutical, organizational and legal study of the problem of formation, development and spread of polydrug addiction in modern conditions. SSP Modern Pharmacy and Medicine. 2022. Vol.2. No.2. P.1-18. URL: https://doi.org/10.53933/sspmpm.v2i2.49 DOI: https://doi.org/10.53933/sspmpm.v2i2.49

Soh A., Chee C., Wang Yee-Tang et al. Dietary intake of antioxidant vitamins and carotenoids and risk of developing active Tuberculosis in a prospective population-based cohort study. Am J Epidemiol. 2017. Vol.186. Iss.4. P.491–500. Doi: 10.1093/aje/kwx132. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860054/ DOI: https://doi.org/10.1093/aje/kwx132

On the approval of the sixteenth issue of the State Formulary of Medicines and ensuring its availability. Order of the Ministry of Health of Ukraine No. 418 dated 12.03.2024. URL: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-12032024--418-pro-zatverdzhennja-shistnadcjatogo-vipusku-derzhavnogo-formuljara-likarskih-zasobiv-ta-zabezpechennja-jogo-dostupnosti

State register of medicines. State Expert Center of the Ministry of Health of Ukraine. URL: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument

Klymyshina S.O., Tsynetska A.V., Rachkevich L.V. Pharmaceutical cosmetology. Danylo Halytsky Lviv National Medical University, 2008. 227 p.

Shapovalov V.V., Shapovalova V.O., Tkachenko V.G. et al. Work program of the cycle of thematic improvement "Tuberculosis: medical and pharmaceutical assistance, legal support". DZ "LDMU". Approved (protocol No. 4 dated April 10, 2023). 2023. 12 p.

Shapovalova V.O., Shapovalov V.V., Osintseva A.O. et al. Working program of normative educational component 26 "Pharmacognosy". Rivne: DZ "LDMU". 2023. 19 p. (Minutes of the meeting of the university council on the quality of education dated August 31, 2023, No. 1).

Osyntseva A.O., Shapovalova V.O., Shapovalov V.V. Work program of normative educational component 32 "Resource science of medicinal plants". Rivne: DZ "LDMU". 2023. 18 p. (Minutes of the meeting of the university council on the quality of education dated August 31, 2023, No. 1).

Kyslychenko V.S., Zhuravel I.O., Marchyshyn S.M. Pharmacognosy. Kharkiv: NFaU, 2015. 736 p.

Tkachenko V.G., Shapovalova V.O., Shapovalov V.V. et al. A collection of preparation materials for the unified state qualification exam (UEKI) on the educational component of Pharmacognosy. Rivne: DZ "LDMU" 2023. 36 p. (Protocol No. 2 dated September 26, 2023).

Shapovalova V.O., Shapovalov V.V., Osintseva A.O. Materials for ensuring the final control of the educational component Pharmacognosy. Rivne: DZ "LDMU" 2023. 36p. (Protocol No. 1 dated August 31, 2023). DOI: https://doi.org/10.52422/23077832_2023_1_31

Shapovalova V.O., Shapovalov V.V., Okseniuk O.E. et al. Work program of the pre-certification cycle in the specialty "Pharmacy". Rivne: DZ "LDMU". 2023. 18 p. (Minutes of the academic council meeting dated October 26, 2023 No. 3).

Tuberculosis treatment: coverage and outcomes. WHO. 2022. URL: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023/tb-diagnosis---treatment/tb-treatment-and-treatment-coverage

Shapovalov (Jr.) V., A. Gudzеnko, Shapovalova V. et al. Organizational, legal and marketing characteristics of domestic medicines for pharmaceutical provision to victims suffered from emergency situations in Ukraine. The Pharma Innovation Journal. 2018. Vol.7. Iss.6. P. 586–589. URL: http://www.thepharmajournal.com/archives/2018/vol7issue6/PartI/7-5-100-255.pdf

Shapovalov (Jr.) V., A. Gudzеnko, Shapovalova V. et al. Organizational and legal aspects of the use of pharmacoeconomic analysis of multivitamin complexes for pharmaceutical provision of military personnel. The Pharma Innovation Journal. 2018. Vol. 7. Iss. 10. P. 166–169. URL: http://www.thepharmajournal.com/archives/2018/vol7issue10/PartD/7-7-147-579.pdf

Zbrozhek S.I., Shapovalov V.V. (Jr.), Shapovalova V.O., Shapovalov V.V. Organizational and legal, forensic and pharmaceutical, marketing and pharmacoeconomic characteristics of analgesic drugs in the pharmacotherapy of cancer patients: methodical recommendations. Kharkiv, 2018. 36 p.

Shapovalov V.V., Shapovalova V.O., Shapovalov V.V. Experience of Great Britain in organization of healthcare system for pharmaceutical provision with medicines for privileged categories of citizens. Health of society. 2019. Vol. 78. No. 1. P. 36–40. DOI: 10.22141/2306-2436.8. 1.2019.172617. URL: https://health-society.zaslavsky.com.ua/index.php/journal/article/view/188.

Gudzenko A., Shapovalov V., Shapovalova V., Shapovalov V. Organization and legal aspects of the use of marketing analysis of multivitamin complexes for pharmaceutical provision of health diseases among combatants. Acta scientific pharmaceutical sciences. 2021. V.5. Iss.4. P.74-80. DOI: 10.31080/ASPS.2021.05.0704 DOI: https://doi.org/10.31080/ASPS.2021.05.0704

Chuiev Y., Shapovalova V. Interdisciplinary pharmacoeconomic study of pharmacotherapy of cupping of drunk forms of alcohol dependence: clinical and pharmacological, organizational, legal and marketing experiment. SSP Modern Pharmacy and Medicine. 2021. Vol.1. No.2. P.1–12. URL: https://doi.org/10.53933/sspmpm.v1i2.24 DOI: https://doi.org/10.53933/sspmpm.v1i2.24

Downloads

Published

2024-07-23

How to Cite

Osyntseva, A. (2024). Use of B Vitamins in Pharmacotherapy of Tuberculosis: Retrospective and Marketing Analysis. SSP Modern Pharmacy and Medicine, 4(3), 1–26. https://doi.org/10.53933/sspmpm.v4i3.154

Issue

Section

Health Sciences. Pharmacy